Detail Information of Transcriptional Regulations
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0027 Transporter Info | ||||
| Gene Name | SLC22A12 | ||||
| Transporter Name | Urate anion exchanger 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Transcriptional Regulation of This DT (TSR) | ||||||
|---|---|---|---|---|---|---|
|
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
ESR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Activation of SLC22A12 gene in hepatoblastoma condition | [1] | ||||
|
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
|
Affected Drug/Substrate |
Uric acid | |||||
|
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
|
Tissue |
Liver | |||||
|
Related DT Changes |
Up regulating | |||||
|
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
|
Detailed Description |
Estrogen receptor (ESR1) has been reported to activate the transcription of SLC22A12 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Urate anion exchanger 1. | |||||
|
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Binding to SLC22A12 gene in erythroleukemia condition | [2] | ||||
|
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
|
Studied Phenotype |
. | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of SLC22A12 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Urate anion exchanger 1. | |||||
|
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
HNF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Activation of SLC22A12 gene in health condition | [3] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 1-alpha | Transcription Factor Info | ||||
|
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
|
Tissue |
Kidney | |||||
|
Related DT Changes |
Up regulating | |||||
|
Experimental Material |
Hnf1a KO mice | |||||
|
Detailed Description |
Hepatocyte nuclear factor 1-alpha (HNF1A) has been reported to activate the transcription of SLC22A12 gene in health condition, which leads to an increased expression of the drug transporter Urate anion exchanger 1. | |||||
|
HNF1B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Activation of SLC22A12 gene in health condition | [3] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 1-beta | Transcription Factor Info | ||||
|
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
|
Tissue |
Kidney | |||||
|
Related DT Changes |
Up regulating | |||||
|
Experimental Material |
Hnf1a KO mice | |||||
|
Detailed Description |
Hepatocyte nuclear factor 1-beta (HNF1B) has been reported to activate the transcription of SLC22A12 gene in health condition, which leads to an increased expression of the drug transporter Urate anion exchanger 1. | |||||
|
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
|
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Binding to SLC22A12 gene in epithelial ovarian cancer condition | [4] | ||||
|
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
|
Studied Phenotype |
. | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC22A12 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Urate anion exchanger 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.